Found 21 matching trials
Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery PHASE3 The primary objective of this study is to evaluate the effects of enoxapari...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function PHASE4 This is a clinical trial including non-surgical patients, 70 years of age o...
Show More Location
LAU Medical Center-Rizk Hospital
Learn More & Join Trial
Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 PHASE3 In a 2x2 factorial design randomized controlled trial, the investigators ai...
Show More Location
Masih Daneshvari Hospital
Learn More & Join Trial
A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty PHASE3 The objective of this study is to assess the efficacy and safety of DU-176b...
Show More Location
Multiple Locations
Learn More & Join Trial
Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial PHASE4 Pragmatic randomized clinical trial of patients admitted to the hospital wi...
Show More Location
Hospital Maternidade São Vicente de Paulo
Learn More & Join Trial
Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF) PHASE4 Vitamin K antagonists (VKAs) are used to reduce the risk of stroke (cerebra...
Show More Location
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine
Learn More & Join Trial
Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study NA The EINSTEIN program showed that oral rivaroxaban is effective and safe tre...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study PHASE2 The study drug, BAY59-7939, is a new drug currently being tested in the pre...
Show More Location
Multiple Locations
Learn More & Join Trial
S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma PHASE2 RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Show More Location
Tulane Cancer Center Office of Clinical Research
Learn More & Join Trial
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty PHASE3 The objective of this study is to assess the efficacy and safety of DU-176b...
Show More Location
Multiple Locations
Learn More & Join Trial